Interventional Cardiology Devices Market, Competitive Landscape and Market Forecast–2026
What are Interventional Cardiology Devices?
Interventional Cardiology devices are used in the diagnosis and treatment of patients suffering from cardiovascular diseases. Such procedures lead to fewer patient injuries and ensure a faster recovery and, therefore, shorter hospital time.
What is the market for Global Interventional Cardiology Devices?
Global Interventional Cardiology Devices Market was valued at USD 12.41 billion in 2020, growing at a CAGR of 6.53% during the forecast period from 2021 to 2026, to reach USD 18.36 billion by 2026.
Key Recent Developmental Activities in the Interventional Cardiology Devices Market:
· In July 2021, Medtronic PLC, the global leader in medical technology, announced the launch of the Prevail™ drug-coated balloon (DCB) Catheter in Europe following the CE (Conformité Européene) mark. The newest coronary DCB on the market, the Prevail DCB is used during percutaneous coronary intervention (PCI) procedures to treat narrowed or blocked coronary arteries in patients with coronary artery disease (CAD).
· In June 2020, Edward Lifesciences Corporation (US) has received Chinese regulatory approval for the SAPIEN 3 Transcatheter Heart Valve for the treatment of patients suffering from severe, symptomatic aortic stenosis (AS) who are unable to undergo open-heart surgery.
What are the market drivers for Global Interventional Cardiology Devices?
The major drivers driving the demand for Interventional Cardiology Devices are the growing prevalence of cardiovascular diseases (CVDs) in the rising geriatric population, technological advancements in product development, the increasing adoption rates of minimally invasive surgeries, and increasing awareness programs regarding cardiovascular diseases.
Request sample report of Interventional Cardiology Devices Market @ https://www.delveinsight.com/report-store/interventional-cardiology-devices-market
What are the market barriers for Global Interventional Cardiology Devices?
The non-availability of the advanced products, product recalls, high treatment costs and limitations regarding the safety of devices may prove to be certain restraints to the Interventional Cardiology Devices market growth.
What are the key players operating in Global Interventional Cardiology Devices?
Some of the key market players operating in the Interventional Cardiology Devices market include Edwards Lifesciences Corporation, Abbott Laboratories, Boston Scientific Corporation, ACIST Medical Systems, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, Medtronic PLC., Teleflex Incorporated, B Braun Melsungen AG, MicroPort Scientific Corporation, SIS MEDICAL AG Lepu Medical Technology Co. Ltd., Terumo Corporation, Sahajanand Laser Technology Limited, Biotronik SE & Co. KG and others.
What regions have the highest share in the Interventional Cardiology Devices market?
North America is expected to dominate the overall Interventional Cardiology Devices market during the forecast period, 2021 to 2026. This domination is due to the growing prevalence of cardiovascular diseases, access to better healthcare infrastructure coupled with the presence of major market players in the region.
Request sample report of Interventional Cardiology Devices Market @ https://www.delveinsight.com/sample-request/interventional-cardiology-devices-market